HPV: Wastewater Surveillance to Better Understand Papillomavirus Circulation

A new scientific approach aims to refine epidemiological knowledge and strengthen the prevention of sexually transmitted infections.

Generic image: generic laboratory image featuring a petri dish with a viral sample.
AI

Generic image: generic laboratory image featuring a petri dish with a viral sample.

An innovative approach using wastewater analysis allows for better monitoring of human papillomavirus (HPV) circulation, a common infection with variable consequences ranging from cancers to ENT infections.

Widely prevalent, human papillomaviruses (HPV) exist in over 200 types, at least 12 of which can cause cancers in both women and men. However, their circulation within the population remains poorly understood. The Impact-HPV project, supported by ASU-GHI and led by Pauline Michon, a doctoral student in the Obépine+ program, and Vincent Maréchal, a virologist and director of this program, is exploring a new avenue for better monitoring: wastewater analysis. The ambition is twofold: to refine epidemiological knowledge and to leverage this data for prevention, particularly among the student community.
For several years, wastewater epidemiology projects have been multiplying globally to track the circulation of various pathogens. The goal is to translate this data into concrete public health actions. Vincent Maréchal and his team, as part of the Obépine+ program, have launched a project dedicated to monitoring sexually transmitted infections (STIs). This approach addresses the limitations of traditional epidemiological data, which are often underreported and may not accurately reflect the real-time situation, partly due to unequal access to testing and the asymptomatic nature of some infections.
In 2024, the European Centre for Disease Prevention and Control (ECDC) alerted to a sharp rise in STIs observed since 2022. Vincent Maréchal attributes this trend to weakened prevention, including a decrease in condom use with the advent of effective HIV treatments, as well as difficulties in accessing testing and changes in sexual practices, especially among young people, facilitated by dating apps. Doctoral student Pauline Michon also highlights that the consequences of HPV infections beyond cervical cancer, such as head and neck, penile, or anal cancers, are still poorly understood and their incidence is increasing in men.
HPV infection is very common, with 80% of men and women likely to contract an HPV during their sexual lives. However, infection does not automatically lead to cancer; in most cases, the immune system clears the virus spontaneously within months to two years. Only certain HPV types, known as oncogenic or high-risk, are associated with cancers (cervical, anal, penile, head and neck). Persistent infection with these types can lead to abnormal cell development that may progress to cancer. Cervical cancer screening, recommended for women from age 25, aims to detect these anomalies. However, screening results do not necessarily reflect the entire population's situation, particularly for men, and there is no equivalent organized screening for HPV-related head and neck cancers.
To obtain a more comprehensive picture of circulating HPV genotypes, a method complementary to traditional, lengthy, and costly surveys was needed. Vincent Maréchal explains the use of wastewater epidemiology to study the most prevalent genotypes in the population, across all age groups and sexes. The principle involves detecting viral traces in wastewater, allowing for results almost in real-time, approximately 24 to 48 hours after viral excretion. Pauline Michon conducted analyses on 100 samples collected over a year from a Parisian wastewater treatment plant, in collaboration with SIAAP, confirming the feasibility of HPV detection in wastewater.
A key advantage of this approach is the ability to track the circulation of different HPV genotypes, particularly those targeted by vaccination. In France, the Gardasil 9 vaccine protects against nine types of papillomaviruses. Pauline Michon detected HPV 6 in nearly 95% of samples and HPV 16 in over 20%, raising questions about vaccination coverage and its effectiveness. While vaccination does not eliminate the need for screening, it remains crucial for infection prevention. New avenues are being explored, such as searching for anti-HPV antibodies in wastewater to estimate the population's overall immunity level.
Following an initial phase of sampling at a Parisian wastewater treatment plant, funded by ANRS-MIE as part of the Papill’Eau project, research continues on the Pierre-et-Marie-Curie campus of Sorbonne Université. These analyses will feed into the Impact HPV project, led by ASU-GHI, to raise awareness among the student community, who are particularly affected by STIs and HPV infections. The project will collaborate with the university's Student Health Service to enhance STI prevention and encourage HPV vaccination. Initial student reactions, announcing their intention to get vaccinated after hearing about the results, highlight the potential of this scientific data as a prevention tool.
The project also plans to collaborate with sociologists from GEMASS to better understand students' knowledge and practices. Vincent Maréchal emphasizes the importance of not isolating the issue of infections from broader sexual health concerns, including consent, pleasure, violence, and stigma. Ultimately, Impact HPV aims to deepen knowledge on papillomavirus circulation and make these findings accessible to the public, with potential expansion to other regions like Grand Est and French Guiana.
Based on information from the official source: Sorbonne Université (10/11/2026)